The Global Cancer Immunotherapy Market was valued at USD 95.69 Billion in 2024 and is expected to reach USD 28.27 Billion by 2032, growing at a CAGR of 15.5% (2025-2032).
The Global Cancer Immunotherapy Market was valued at USD 95.69 Billion in 2024 and is expected to reach USD 28.27 Billion by 2032, growing at a CAGR of 15.5% (2025-2032).
The Global Breakthrough Immunotherapy Drug Market was valued at USD 792.00 Million in 2025 and is expected to reach USD 1,764.00 Million by 2033, growing at a CAGR of 10.5% (2026-2033).
The Global Personalized Cancer Vaccines Market was valued at USD 234,790.00 Million in 2022 and is expected to reach USD 371,404.60 Million by 2030, growing at a CAGR of 5.9% (2023-2030).